Evidence map›Paper›PMID 35647287›Full record

ArticleACS central science2022

Durable Surfaces from Film-Forming Silver Assemblies for Long-Term Zero Bacterial Adhesion without Toxicity.

Hossein Yazdani-Ahmadabadi, Demian F Felix, Kai Yu, Han H Yeh, Haiming D Luo, Sara Khoddami, Lily E Takeuchi, Amal Alzahrani, Srinivas Abbina, Yan Mei and 4 more

Abstract read
In one paragraph

Article in ACS central science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hossein Yazdani-AhmadabadiDepartment of Chemistry, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.
Demian F FelixThe Stone Centre at Vancouver General Hospital, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada.
Kai YuCentre for Blood Research, Life Science Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.
Han H YehDepartment of Mechanical Engineering, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada.
Haiming D LuoDepartment of Chemistry, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.
Sara KhoddamiThe Stone Centre at Vancouver General Hospital, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada.
Lily E TakeuchiCentre for Blood Research, Life Science Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.
Amal AlzahraniThe Stone Centre at Vancouver General Hospital, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada.
Srinivas AbbinaCentre for Blood Research, Life Science Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.
Yan MeiCentre for Blood Research, Life Science Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.ORCID https://orcid.org/0000-0003-2500-0659
Ladan FazliVancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia V6H 3Z6, Canada.
Dana GrecovDepartment of Mechanical Engineering, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada.
Dirk LangeThe Stone Centre at Vancouver General Hospital, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada.
Jayachandran N KizhakkedathuDepartment of Chemistry, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.ORCID https://orcid.org/0000-0001-7688-7574

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The long-term prevention of biofilm formation on the surface of indwelling medical devices remains a challenge. Silver has been reutilized in recent years for combating biofilm formation due to its indisputable bactericidal potency; however, the toxicity, low stability, and short-term activity of the current silver coatings have limited their use. Here, we report the development of silver-based film-forming antibacterial engineered (SAFE) assemblies for the generation of durable lubricous antibiofilm surface long-term activity without silver toxicity that was applicable to diverse materials via a highly scalable dip/spray/solution-skinning process. The SAFE coating was obtained through a large-scale screening, resulting in effective incorporation of silver nanoparticles (∼10 nm) into a stable nonsticky coating with high surface hierarchy and coverage, which guaranteed sustained silver release. The lead coating showed zero bacterial adhesion over a 1 month experiment in the presence of a high load of diverse bacteria, including difficult-to-kill and stone-forming strains. The SAFE coating showed high biocompatibility and excellent antibiofilm activity

Identifiers

PMID35647287
PMCPMC9136974

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.